The not-for-profit Whittemore Peterson Institute (WPI) was founded in 2005 to support those with neuro-immune diseases (NIDs) such as myalgic encephalomyelitis (ME) and fibromyalgia. They provide scientific discovery and access to treatments for patients through grant support for institute-based clinical research studies and onsite medical practices. The WPI collaborates with basic researchers to advance scientific knowledge, promotes disease awareness through educational activities, advocates for funding of clinical centers of excellence, and supports the local and international patient communities through various outreach activities. Their vision is to be a comprehensive center dedicated to translating scientific evidence into medical treatments, prevention strategies, and cures for those impacted by NIDs.